Icl Israel Chemicals Stock Current Asset
| ICL Stock | USD 4.28 0.11 2.51% |
ICL Israel Chemicals fundamentals help investors to digest information that contributes to ICL Israel's financial success or failures. It also enables traders to predict the movement of ICL Stock. The fundamental analysis module provides a way to measure ICL Israel's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ICL Israel stock.
ICL |
ICL Israel Chemicals Company Current Asset Analysis
ICL Israel's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current ICL Israel Current Asset | 2.98 B |
Most of ICL Israel's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ICL Israel Chemicals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, ICL Israel Chemicals has a Current Asset of 2.98 B. This is 44.33% lower than that of the Chemicals sector and 96.5% higher than that of the Materials industry. The current asset for all United States stocks is 68.03% higher than that of the company.
ICL Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ICL Israel's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ICL Israel could also be used in its relative valuation, which is a method of valuing ICL Israel by comparing valuation metrics of similar companies.ICL Israel is currently under evaluation in current asset category among its peers.
ICL Fundamentals
| Return On Equity | 0.081 | ||||
| Return On Asset | 0.0426 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 7.44 B | ||||
| Shares Outstanding | 1.29 B | ||||
| Shares Owned By Insiders | 44.05 % | ||||
| Shares Owned By Institutions | 26.10 % | ||||
| Number Of Shares Shorted | 1 M | ||||
| Price To Earning | 918.89 X | ||||
| Price To Book | 0.93 X | ||||
| Price To Sales | 0.76 X | ||||
| Revenue | 7.65 B | ||||
| Gross Profit | 5.03 B | ||||
| EBITDA | 1.81 B | ||||
| Net Income | 657.17 M | ||||
| Cash And Equivalents | 516 M | ||||
| Cash Per Share | 0.40 X | ||||
| Total Debt | 2.66 B | ||||
| Debt To Equity | 0.51 % | ||||
| Current Ratio | 1.65 X | ||||
| Book Value Per Share | 4.46 X | ||||
| Cash Flow From Operations | 1.62 B | ||||
| Short Ratio | 1.00 X | ||||
| Earnings Per Share | 0.33 X | ||||
| Price To Earnings To Growth | 9.44 X | ||||
| Target Price | 4.74 | ||||
| Number Of Employees | 12 K | ||||
| Beta | 1.26 | ||||
| Market Capitalization | 5.38 B | ||||
| Total Asset | 11.53 B | ||||
| Retained Earnings | 5.54 B | ||||
| Working Capital | 1.4 B | ||||
| Current Asset | 2.98 B | ||||
| Current Liabilities | 2.05 B | ||||
| Annual Yield | 0.05 % | ||||
| Five Year Return | 3.55 % | ||||
| Net Asset | 11.53 B | ||||
| Last Dividend Paid | 0.2 |
About ICL Israel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ICL Israel Chemicals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICL Israel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICL Israel Chemicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out ICL Israel Piotroski F Score and ICL Israel Altman Z Score analysis. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.